ArticleACR open rheumatology2022

Minimal Impact of the COVID-19 Pandemic on Disease Activity and Health-Related Quality of Life in Patients With Ankylosing Spondylitis Receiving Bimekizumab: Exploratory Analyses From a Phase 2b Open-Label Extension Study.

Philip C Robinson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.